InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Van Hauwermeiren Timothy. Director active across 2 companies, notably iTeos Therapeutics, Inc.. Aggregated, 3 reports have been recorded. History available since 13 May 2025. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条